E2	Eq-Comparison:T5 Temporal-Unit:T7 Value:T6 Operator:T8
E3	Age:T9 Numeric-Filter:E2
E4	Observation:T10 Name:T11
E5	Observation:T12 Name:T13 Numeric-Filter:E8
E6	Study:T14
E8	Eq-Comparison:T16 Operator:T17 Value:T18 Per:T19
E9	Eq-Comparison:T20 Operator:T21 Value:T22 Per:T23
E11	Immunization:T25 Name:T26 Temporality:E12 Temporality2:E74
E12	Eq-Comparison:T27 Temporal-Unit:T30 Operator:T28 Value:T29
E13	Study:T31
E15	Observation:T33 Name:T34
E16	Observation:T35 Name:T36 Numeric-Filter:E17
E17	Eq-Comparison:T37 Operator:T38 Value:T39 Unit:T40 Per:T41
E18	Eq-Comparison:T42 Operator:T43 Value:T44 Unit:T45 Per:T46
E20	Study:T48
E22	Condition:T50 Name:T51 Acuteness:T52
E26	Condition:T55 Name:T56
E27	Condition:T57 Name:T58
E28	Condition:T59 Name:T60
E29	Condition:T61 Name:T62
E30	Condition:T63 Name:T64
E31	Modifier:T65 Modifies:T64
E32	Modifier:T66 Modifies:T64
E34	Condition:T68 Name:T69
E35	Condition:T70 Name:T71
E36	Condition:T72 Name:T73
E37	Condition:T74 Name:T75
E39	Drug:T77 Name:T78 Temporality:E42
E40	Drug:T79 Name:T80
E42	Eq-Comparison:T82 Temporal-Period:T83
E43	Condition:T84 Name:T85 Temporality:E45 Stability:T144
E44	Study:T86
E45	Eq-Comparison:T87 Operator:T88 Temporal-Unit:T90 Value:T89
E47	Drug:T92 Name:T93 Temporality:E49 Temporality2:E75
E48	Study:T94
E49	Eq-Comparison:T95 Temporal-Unit:T98 Operator:T96 Value:T97
E51	Condition:T100 Name:T101
E52	Assertion:T102 Asserted:E51
E53	Modifier:T103 Modifies:T101
E54	Modifier:T104 Modifies:T101
E56	Observation:T106 Name:T107 Temporality:E58
E57	Study:T108
E58	Eq-Comparison:T109 Temporal-Unit:T112 Operator:T110 Value:T111
E60	Observation:T114 Name:T115
E61	Observation:T116 Name:T117 Numeric-Filter:E64
E62	Observation:T118 Name:T119
E63	Observation:T120 Name:T121 Numeric-Filter:E64
E64	Eq-Comparison:T122 Operator:T123 Unit:T125 Value:T124
E65	Observation:T126 Name:T127
E66	Eq-Comparison:T128 Value:T130 Operator:T129 Unit2:T131 Per:T132
E67	Condition:T133 Name:T134
E68	Condition:T135 Name:T136
E70	Condition:T138 Name:T139
E71	Drug:T141 Name:T142
E72	Assertion:T143 Asserted:E73
E73	Negation:T145 Negates:E71
E74	Eq-Comparison:T146 Temporal-Period:T147
E75	Eq-Comparison:T148 Temporal-Period:T149
T1	Life-Stage-And-Gender 25 30	Adult
T2	Life-Stage-And-Gender 31 34	men
T3	Life-Stage-And-Gender 39 44	women
T5	Eq-Comparison 45 58	over 50 years
T6	Eq-Value 50 52	50
T7	Eq-Temporal-Unit 53 58	years
T8	Eq-Operator 45 49	over
T9	Age 53 58	years
T10	Observation 266 282	white blood cell
T11	Observation-Name 266 282	white blood cell
T12	Observation 283 286	WBC
T13	Observation-Name 283 286	WBC
T14	Study 241 250	screening
T16	Eq-Comparison 291 307	less than 3000/㎕
T17	Eq-Operator 291 300	less than
T18	Eq-Value 301 305	3000
T19	Eq-Unit 306 307	㎕
T20	Eq-Comparison 311 327	more than 8000/㎕
T21	Eq-Operator 311 320	more than
T22	Eq-Value 321 325	8000
T23	Eq-Unit 326 327	㎕
T25	Immunization 352 373	influenza vaccination
T26	Immunization-Name 352 373	influenza vaccination
T27	Eq-Comparison 374 389	within 3 months
T28	Eq-Operator 374 380	within
T29	Eq-Value 381 382	3
T30	Eq-Temporal-Unit 383 389	months
T31	Study 401 410	screening
T33	Observation 433 448	body mass index
T34	Observation-Name 433 448	body mass index
T35	Observation 449 452	BMI
T36	Observation-Name 449 452	BMI
T37	Eq-Comparison 457 479	less than 18.5 kg / m2
T38	Eq-Operator 457 466	less than
T39	Eq-Value 467 471	18.5
T40	Eq-Unit 472 474	kg
T41	Eq-Unit 477 479	m2
T42	Eq-Comparison 483 506	greater than 35 kg / m2
T43	Eq-Operator 483 495	greater than
T44	Eq-Value 496 498	35
T45	Eq-Unit 499 501	kg
T46	Eq-Unit 504 506	m2
T48	Study 514 523	screening
T50	Condition 586 607	cardiovascular system
T51	Condition-Name 586 607	cardiovascular system
T52	Acuteness 578 585	chronic
T55	Condition 609 625	endocrine system
T56	Condition-Name 609 625	endocrine system
T57	Condition 627 640	immune system
T58	Condition-Name 627 640	immune system
T59	Condition 642 660	respiratory system
T60	Condition-Name 642 660	respiratory system
T61	Condition 662 682	liver biliary system
T62	Condition-Name 662 682	liver biliary system
T63	Condition 703 709	system
T64	Condition-Name 703 709	system
T65	Modifier 695 702	urinary
T66	Modifier 684 690	kidney
T68	Condition 711 726	neuropsychiatry
T69	Condition-Name 711 726	neuropsychiatry
T70	Condition 728 750	musculoskeletal system
T71	Condition-Name 728 750	musculoskeletal system
T72	Condition 752 764	inflammatory
T73	Condition-Name 752 764	inflammatory
T74	Condition 769 780	hematologic
T75	Condition-Name 769 780	hematologic
T77	Drug 803 813	medication
T78	Drug-Name 803 813	medication
T79	Drug 817 837	health function food
T80	Drug-Name 817 837	health function food
T82	Eq-Comparison 796 800	take
T83	Eq-Temporal-Period 796 800	take
T84	Condition 856 877	promotion of immunity
T85	Condition-Name 856 877	promotion of immunity
T86	Study 906 915	screening
T87	Eq-Comparison 878 892	within 1 month
T88	Eq-Operator 878 884	within
T89	Eq-Value 885 886	1
T90	Eq-Temporal-Unit 887 892	month
T92	Drug 945 969	antipsychotic medication
T93	Drug-Name 945 969	antipsychotic medication
T94	Study 993 1002	screening
T95	Eq-Comparison 970 985	within 3 months
T96	Eq-Operator 970 976	within
T97	Eq-Value 977 978	3
T98	Eq-Temporal-Unit 979 985	months
T100	Condition 1036 1041	abuse
T101	Condition-Name 1036 1041	abuse
T102	Assertion 1042 1051	suspected
T103	Modifier 1018 1027	alcoholic
T104	Modifier 1031 1035	drug
T106	Observation 1067 1104	participated in other clinical trials
T107	Observation-Name 1067 1104	participated in other clinical trials
T108	Study 1128 1137	screening
T109	Eq-Comparison 1105 1120	within 3 months
T110	Eq-Operator 1105 1111	within
T111	Eq-Value 1112 1113	3
T112	Eq-Temporal-Unit 1114 1120	months
T114	Observation 1199 1221	Aspartate Transaminase
T115	Observation-Name 1199 1221	Aspartate Transaminase
T116	Observation 1222 1225	AST
T117	Observation-Name 1222 1225	AST
T118	Observation 1228 1248	Alanine Transaminase
T119	Observation-Name 1228 1248	Alanine Transaminase
T120	Observation 1249 1252	ALT
T121	Observation-Name 1249 1252	ALT
T122	Eq-Comparison 1254 1291	> Reference range 3 times upper limit
T123	Eq-Operator 1254 1255	>
T124	Eq-Value 1272 1273	3
T125	Eq-Unit 1280 1291	upper limit
T126	Observation 1302 1318	Serum Creatinine
T127	Observation-Name 1302 1318	Serum Creatinine
T128	Eq-Comparison 1319 1330	> 2.0 mg/dL
T129	Eq-Operator 1319 1320	>
T130	Eq-Value 1321 1324	2.0
T131	Eq-Unit 1325 1327	mg
T132	Eq-Unit 1328 1330	dL
T133	Condition 1336 1345	Pregnancy
T134	Condition-Name 1336 1345	Pregnancy
T135	Condition 1349 1363	breast feeding
T136	Condition-Name 1349 1363	breast feeding
T138	Condition 1447 1459	childbearing
T139	Condition-Name 1447 1459	childbearing
T140	Life-Stage-And-Gender 1460 1465	woman
T141	Drug 1428 1441	contraception
T142	Drug-Name 1428 1441	contraception
T143	Assertion 1387 1393	accept
T144	Stability 843 850	affects
T145	Negation 1379 1386	doesn't
T146	Eq-Comparison 343 351	received
T147	Eq-Temporal-Period 343 351	received
T148	Eq-Comparison 936 944	received
T149	Eq-Temporal-Period 936 944	received
T53	Acuteness 569 574	acute
A1	Life-Stage-And-Gender-Type T1 adult
A2	Life-Stage-And-Gender-Type T2 male
A3	Life-Stage-And-Gender-Type T3 female
A4	Eq-Temporal-Unit-Value T7 year
A5	Eq-Operator-Value T8 GT
A6	Observation-Type-Value E4 lab
A7	Observation-Type-Value E5 lab
A9	Eq-Operator-Value T17 LT
A10	Eq-Operator-Value T21 GT
A11	Eq-Operator-Value T28 LTEQ
A12	Eq-Temporal-Unit-Value T30 month
A14	Observation-Type-Value E15 vital
A15	Observation-Type-Value E16 vital
A16	Eq-Operator-Value T38 LT
A17	Eq-Operator-Value T43 GT
A19	Eq-Temporal-Period-Value T83 present
A20	Eq-Operator-Value T88 LTEQ
A21	Eq-Temporal-Unit-Value T90 month
A23	Eq-Operator-Value T96 LTEQ
A24	Eq-Temporal-Unit-Value T98 month
A26	Assertion-Type-Value E52 possible
A27	Eq-Operator-Value T110 LTEQ
A28	Eq-Temporal-Unit-Value T112 month
A30	Observation-Type-Value E60 lab
A31	Observation-Type-Value E61 lab
A32	Observation-Type-Value E62 lab
A33	Observation-Type-Value E63 lab
A34	Eq-Operator-Value T123 GT
A35	Eq-Unit-Value T125 ref-range-high
A36	Observation-Type-Value E65 lab
A37	Eq-Operator-Value T129 GT
A38	Life-Stage-And-Gender-Type T140 female
A39	Assertion-Type-Value E72 hypothetical
A40	Stability-Value T144 change
A41	Eq-Temporal-Period-Value T147 past
A42	Eq-Temporal-Period-Value T149 past
A44	Acuteness-Type-Value T53 acute
A45	Acuteness-Type-Value T52 chronic
R1	Abbrev-Of Arg1:E5 Arg2:E4
R2	Abbrev-Of Arg1:E16 Arg2:E15
R4	Abbrev-Of Arg1:E61 Arg2:E60
R5	Abbrev-Of Arg1:E63 Arg2:E62
R6	If-Then Arg1:T140 Arg2:E70
R7	Treatment-For Arg1:E71 Arg2:E70
R3	Caused-By Arg1:T144 Arg2:E40
R8	Or Arg1:T2 Arg2:T3
R9	During Arg1:E6 Arg2:E4
R10	Or Arg1:E8 Arg2:E9
R11	Before Arg1:E12 Arg2:E13
R12	Or Arg1:E17 Arg2:E18
R13	During Arg1:E16 Arg2:E20
R14	Or Arg1:T53 Arg2:T52
R15	Or Arg1:E32 Arg2:E31
R16	Or Arg1:E36 Arg2:E37
R17	Or Arg1:E39 Arg2:E40
R18	Before Arg1:E45 Arg2:E44
R19	Before Arg1:E49 Arg2:E48
R20	Or Arg1:E53 Arg2:E54
R21	Before Arg1:E58 Arg2:E57
R22	Or Arg1:E67 Arg2:E68
R23	Or Arg1:E22 Arg2:E26
R24	Or Arg1:E26 Arg2:E27
R25	Or Arg1:E27 Arg2:E28
R26	Or Arg1:E28 Arg2:E29
R27	Or Arg1:E30 Arg2:E34
R28	Or Arg1:E34 Arg2:E35
R29	Or Arg1:E35 Arg2:E36